Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalgety Animal Health was a prominent veterinary pharmaceutical company and a subsidiary of the British conglomerate Dalgety PLC. The company specialized in providing health solutions for the livestock industry, with a particular focus on vaccines and parasiticides for sheep, cattle, and pigs. Its product portfolio was widely utilized in major agricultural markets, including the United Kingdom, Australia, and New Zealand. In 1998, Dalgety PLC divested the animal health division to Schering-Plough for approximately £28 million to refocus on its core agribusiness and genetic improvement operations. Following subsequent industry consolidations, the business is now part of MSD Animal Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalgety Animal Health.